BioSpace News Archive

Policy

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Rockwell Medical, and Impinj and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that class action lawsuits have been commenced on behalf of stockholders of Mercury Systems, Inc., Rockwell Medical, Inc., and Impinj, Inc.

August 7, 2018
·
2 min read
Policy

I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202

On August 8, 2018 Beijing time I-Mab Biopharma and MorphoSys AG announced today that I-Mab has Submitted an investigational new drug (IND) application to China National Drug Administration (CNDA) for TJ202/MOR202, a human monoclonal antibody directed against CD38 for the treatment of multiple myeloma.

August 7, 2018
·
7 min read
Deals

ProLung Shareholder Group Led by Founder and Former CEO Steve Eror Files Preliminary Consent Materials for the Addition of 8 New Directors to the Board

Cautions the Board Against any Further Board Appointments or Governance Changes During the Pendency of the Consent Solicitation

August 7, 2018
·
5 min read
Business

CORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update

CORRECTION...by Synergy Pharmaceuticals Inc.

August 7, 2018
·
16 min read
Biotech Bay

Natera Clinical Study Validates New Biomarker for Aneuploidy and Adverse Pregnancy Outcomes

Study Highlights Proprietary Technology for Fetal Fraction Measurement in Non-Invasive Prenatal Testing

August 7, 2018
·
5 min read
Business

Aptimmune Biologics and Kemin Industries Announce Partnership

Kemin Industries acquires equity position in Aptimmune Biologics and creates Kemin Biologics to market Aptimmune’s Barricade™ technology in swine

August 7, 2018
·
3 min read
FDA

FDA Approves ORKAMBI® (lumacaftor/ivacaftor) as First Medicine to Treat the Underlying Cause of Cystic Fibrosis for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI®.

August 7, 2018
·
9 min read
Drug Development

Lafayette General Medical Center Unveils Xenex LightStrike Germ-Zapping Robots

New technology destroys deadly pathogens and bacteria lurking on hospital surfaces

August 7, 2018
·
4 min read
Business

MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

MacroGenics, Inc. provided an update on its corporate progress and reported financial results for the quarter ended June 30, 2018.

August 7, 2018
·
10 min read
Business

Streamline Health Names ‘Tee’ Green, Former CEO of Greenway Medical Health to its Board of Directors

Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises, today announced the board of directors appointed Wyche T. “Tee” Green, III to the Board effective immediately.

August 7, 2018
·
2 min read